Wells Fargo analyst Timothy Daley lowered the firm’s price target on Thermo Fisher to $505 from $525 and keeps an Underweight rating on the shares. The analyst notes that in late 2021, the company upgraded its long-term growth guidance framework by +200bps to 7%-9% and while technically a multi-year average, the market still views this as a hard "bracketed" range and has set 7%-9% as the bogey for 2023. Given his incrementally bearish view on key growth drivers for 2023, Daley sees this as a very aggressive hurdle under the backdrop of Thermo Fisher’s history of consistently setting initial annual guidance with ample headroom for beat/raise progression through the year. His view is the JPMorgan conference will be the capitulation point where management will have to finally talk down these unrealistic expectations.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on TMO:
- Thermo Fisher completes acquisition of The Binding Site Group, sees accretion
- Aslan, Thermo Fisher announce partnership for manufacturing eblasakimab
- Thermo Fisher’s monkeypox test granted emergency use authorization by FDA
- Thermo Fisher initiated with a Buy at Deutsche Bank
- Thermo Fisher Stock (NYSE:TMO): Is Its Superb Quality Worth the Price?